Evidence map›Paper›PMID 27220640›Full record

ReviewNature reviews. Molecular cell biology2016

Introducing STRaNDs: shuttling transcriptional regulators that are non-DNA binding.

Min Lu, Mary R Muers, Xin Lu

2 registry-linked trialsAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Molecular cell biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03377725 phase3withdrawnnot on this mapstarted 2018, after this paper: background citation

Decitabine and Arsenic Trioxide(ATO) in the Treatment of Myelodysplasic Syndrome

TypeinterventionalSponsorLi JunminRan2018 to 2018Enrolled0ConditionsMyelodysplastic Syndromes, P53 MutationArmsDecitabine, Arsenic Trioxide
NCT03381781 phase2unknown statusnot on this mapstarted 2018, after this paper: background citation

Decitabine,Cytarabine(Ara-C) and Arsenic Trioxide(ATO) in the Treatment of Acute Myeloid Leukemia With p53 Mutations

TypeinterventionalSponsorLi JunminRan2018 to 2020Enrolled100ConditionsAcute Myeloid Leukemia, P53 MutationArmsDecitabine, Arsenic Trioxide, Cytarabine
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Characterisation of a nucleo-adhesome.Nature communications · 2022
    Article
  5. Article
  6. CagA-ASPP2 complex mediates loss of cell polarity and favorsProceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Min LuState Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui Jin Hospital, affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; he was previously at the Ludwig Institute for Cancer Researchuffield Department of Medicine, University of Oxford, UK.
Mary R MuersLudwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, UK.
Xin LuLudwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, UK.
Ludwig Cancer Research · GBUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many proteins originally identified as cytoplasmic - including many associated with the cytoskeleton or cell junctions - are increasingly being found in the nucleus, where they have specific functions. Here, we focus on proteins that translocate from the cytoplasm to the nucleus in response to external signals and regulate transcription without binding to DNA directly (for example, through interaction with transcription factors). We propose that proteins with such characteristics are classified as a distinct group of extracellular signalling effectors, and we suggest the term STRaND (shuttling transcriptional regulators and non-DNA binding) to refer to this group. Crucial roles of STRaNDs include linking cell morphology and adhesion with changes in transcriptional programmes in response to signals such as mechanical stresses.

Indexed as

Signal TransductionCell NucleusCytoplasmDNAGene Expression RegulationHumansIntracellular Signaling Peptides and ProteinsNuclear ProteinsProtein BindingProto-Oncogene Proteins c-yesTranscription FactorsTranscription, GeneticDNAIntracellular Signaling Peptides and ProteinsNuclear ProteinsProto-Oncogene Proteins c-yesTranscription Factors

Identifiers

PMID27220640
OpenAlexW2405806871

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.